Christina Ackermann

Christina Maria Ackermann is currently Secretary & Director at Synergetics USA, Inc., Co-Managing Director at Dr. Robert Winzer Pharma GmbH since 2017, and Independent Non-Executive Director at Oculis Holding AG since 2023.
Former positions include Chairman at Virometix AG (2022–2023), Independent Director at Graybug Vision, Inc. (2021–2023), Independent Non-Executive Director at Verona Pharma Ltd. (2023–2025), Associate General Counsel at DuPont Pharmaceuticals Co. (1996–2000), Senior Vice President & General Counsel at Alcon Laboratories, Inc. (2012–2016), General Counsel & Global Head-Legal at Sandoz International GmbH (2007–2012), Associate General Counsel at Bristol-Myers Squibb Pharma Co. (2001–2002), Head-Legal Technical Operations & Ophthalmics at Novartis Pharma AG (2002–2005), President, Executive VP & General Counsel at Bausch + Lomb Corp.
(2022–2023), and Head-Commercial Operations at Bausch Health Cos., Inc. (2020–2022).
Education includes undergraduate studies at York University and graduate degrees from Queen's University and King's College London.